Moderna’s variant booster candidate has shown encouraging prospects, with preliminary results from human trials in progress revealing that the third dose is efficient in boosting immunity and targeting virus mutations such as South Africa and Brazil variants, as well as removing “its ability to cause serious disease, hospitalization and death.”
“We are encouraged by these new data, which reinforce our confidence that our booster strategy should be protective against these newly detected variants,” confirmed Moderna CEO Stéphane Bancel.
Read also: New COVID-19 Variants: 7 Key Questions Answered By Experts
Let's be honest: we're not always in the mood to go to the gym. Either… READ ON
Among those things that require a lot of focus and ambition, losing weight is one… READ ON
Controlling and understanding your emotions is a rare ability that only a few people have… READ ON
As many gyms have closed due to the pandemic situation, people are getting more and… READ ON
Have you even wondered about the benefits of this vitamin? Vitamin D, also known as… READ ON
Last month, the CDC declared that in areas of the country with high COVID infection… READ ON